Clinical trial Recruiting at 1 site Interventional Ages 16 to 90

Cochlear implants and their effects on tinnitus symptoms

Official title: Effects of Cochlear Implantation on Tinnitus and Its Symptoms

Run by Chinese PLA General Hospital · NCT05453019 · Data updated 2026-11-12

This study is testing whether cochlear implants can help reduce tinnitus symptoms in people with hearing loss by using electrical stimulation.

Quick facts

Study typeInterventional
Ages16 Years to 90 Years
SexAll
Enrollment200 (estimated)
SponsorChinese PLA General Hospital
Academic / other
Locations1 site (Beijing, France)
StatusRecruiting
StartedJuly 4, 2022
Main results expectedJuly 1, 2027
Study endsJuly 1, 2027
Registry record updatedJune 6, 2023
Trial IDNCT05453019 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 16 to 90 who have received cochlear implants and have experienced tinnitus for at least 0.25 years.

Probably not a fit

Patients with non-otogenic tinnitus or those with contraindications for cochlear implant surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of electrical stimulation from cochlear implants on tinnitus symptoms in patients with hearing loss. It aims to analyze changes in tinnitus loudness and frequency before and after cochlear implantation, as well as to explore the underlying mechanisms of how electrical stimulation may inhibit tinnitus. The research will also focus on optimizing stimulation parameters to enhance treatment efficacy. Participants will be monitored over an extended period to assess the long-term effects of the intervention.

Why it matters

Potential benefit: If successful, this study could provide a new therapeutic approach for managing tinnitus in patients with hearing loss.

How similar studies have gone: While there has been progress in using electrical stimulation for tinnitus treatment, this specific approach with cochlear implants is still under investigation and has not been widely tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. This study included patients who received cochlear implants at the Auditory Implant Center of the Otorhinolaryngology-Head and Neck Surgery, China PLA General Hospital;
* 2\. The patients ranged from 16 to 90 years old;
* 3\. The patient experienced hearing loss and had either tinnitus longer than 0.25 years (experimental group 1) or no tinnitus (control group 2) before the cochlear implant surgery;
* 4\. The cochlear implants accepted by patients included products from MED-EL, Cochlear, Advanced Bionics and Nurotron;
* 5\. All patients voluntarily participated in the study.

Exclusion Criteria:

* 1 Tinnitus types exclude non otogenic tinnitus (including tinnitus caused by hypertension, heart disease, hyperthyroidism, neurasthenia, hyperlipidemia, etc.);
* 2 Contraindications of cochlear implant surgery (refer to the guidelines for cochlear implant 2013 of the Chinese Medical Association);
* 3 Intellectual deficiency

Where it's running

  • Qian Wang
    Beijing, France, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.